A pioneering research center in immune-based cancer treatments for more than a century
Immunotherapy was born at Memorial Sloan Kettering Cancer Center (MSK) more than a century ago. The center is home to a diverse group of scientists who study the immune system in all its complexity. They are developing groundbreaking immune therapies that are helping to treat several forms of advanced cancer. The Parker Institute members at MSK are dreaming big – pursuing projects that will not only improve existing immunotherapies but also open the door to new ones.
Research Focuses
Checkpoint Blockade Response
Uncover the reasons why some patients respond to immunotherapy while others may not, in order to overcome cancer drug resistance.
Tumor Microenvironment
Discover how tumor masses impair immune cells to jumpstart the creation of therapies to fight back against hard-to-treat solid tumors.
